naproxen has been researched along with pregabalin in 10 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (pregabalin) | Trials (pregabalin) | Recent Studies (post-2010) (pregabalin) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 2,519 | 555 | 1,809 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadie, C; Bugianesi, RM; Chakravarty, PK; Dai, G; Duffy, JL; Garcia, ML; Green, M; Haedo, RJ; Herrington, JB; Jochnowitz, N; Kaczorowski, GJ; Li, X; Lyons, KA; McGowan, E; McManus, OB; Mistry, S; Shao, PP; Smith, MM; Sun, SY; Swensen, AM; Varughese, DJ; Warren, VA; Ye, F | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bilodeau, MT; Brnardic, EJ; Daley, C; Egbertson, MS; Green, A; Grobler, JA; Hanney, B; Henze, DA; Jones, KL; Kane, SA; Krasowska-Zoladek, A; Lai, MT; Leitl, M; Li, Y; Manley, PJ; Munshi, V; Murphy, D; Nanda, KK; Rickert, K; Riley, D; Rudd, MT; Sanders, JM; Stachel, SJ; Su, HP; Zuck, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altman, RA; Borel, T; Davis, I; de Azambuja, F; Johnson, D; Liu, A; Sorrentino, JP; Udokwu, C; Yang, Y | 1 |
| Chatterjea, D; Hammond, DL; Hurley, RW; Rose Feng, M; Taylor, CP | 1 |
| Beals, C; Drexel, M; Gargano, C; Herman, G; Jackson, A; Johnson-Levonas, AO; Lukac, S; Medve, R; Reicin, A; Ruddy, M; Smiley, P; Wang, H; Webster, L | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Bleakney, R; Gregory, T; Sangha, H | 1 |
| Ängeby Möller, K; Holappa, J; Immonen, J; Stenfors, C; Suominen, A; Svärd, H | 1 |
2 review(s) available for naproxen and pregabalin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
1 trial(s) available for naproxen and pregabalin
| Article | Year |
|---|---|
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics.
Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Hallux Valgus; Humans; Male; Middle Aged; Naproxen; Pain Measurement; Pain, Postoperative; Pregabalin; Treatment Outcome | 2010 |
7 other study(ies) available for naproxen and pregabalin
| Article | Year |
|---|---|
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cells, Cultured; Chronic Pain; Dogs; Humans; Hyperalgesia; Inflammation; Mice; Mice, Knockout; Microsomes, Liver; Neuralgia; Patch-Clamp Techniques; Piperidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tissue Distribution | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.
Topics: Animals; Chronic Pain; Drug Evaluation, Preclinical; Humans; Indoles; Ligands; Models, Molecular; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor, trkA; Small Molecule Libraries; Structure-Activity Relationship; Triazoles; Urea | 2014 |
Diflunisal Derivatives as Modulators of ACMS Decarboxylase Targeting the Tryptophan-Kynurenine Pathway.
Topics: Bacterial Proteins; Binding Sites; Biosynthetic Pathways; Carboxy-Lyases; Catalytic Domain; Crystallography, X-Ray; Diflunisal; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kynurenine; Molecular Docking Simulation; NAD; Pseudomonas fluorescens; Structure-Activity Relationship; Tryptophan | 2021 |
Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia.
Topics: Acetates; Amines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Calcium Channels; Cyclohexanecarboxylic Acids; Drug Synergism; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Naproxen; Pregabalin; Rats; Rats, Sprague-Dawley | 2002 |
Spontaneous resolution of quadrilateral space syndrome: a case report.
Topics: Aged; Analgesics, Opioid; gamma-Aminobutyric Acid; Humans; Male; Naproxen; Nerve Compression Syndromes; Oxycodone; Pregabalin; Remission, Spontaneous; Shoulder; Shoulder Pain; Syndrome; Treatment Outcome; Upper Extremity | 2015 |
Gait analysis and weight bearing in pre-clinical joint pain research.
Topics: Analgesics; Animals; Ankle Joint; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Behavior, Animal; Gait; Gait Analysis; Male; Naproxen; Pregabalin; Rats; Rats, Wistar; Weight-Bearing | 2018 |